Pushpak Bhattacharjee
Kolkata, WB 700054, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Pathogenic Mutations in the C2A Domain of Dysferlin form Amyloid that Activates the Inflammasome.
Journal: bioRxiv : the preprint server for biology
Published: May 10, 2023
The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment.
Journal: Oncogene
Published: June 04, 2019
Andrographolide binds to ATP-binding pocket of VEGFR2 to impede VEGFA-mediated tumor-angiogenesis.
Journal: Scientific reports
Published: July 25, 2018
Cholesterol-dependent cytolysins impair pro-inflammatory macrophage responses.
Journal: Scientific reports
Published: December 11, 2017
Providence of the CD25+ KIR+ CD127- FOXP3- CD8+ T-cell subset determines the dynamics of tumor immune surveillance.
Journal: Immunology and cell biology
Published: August 17, 2017
GPR81, a Cell-Surface Receptor for Lactate, Regulates Intestinal Homeostasis and Protects Mice from Experimental Colitis.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: April 26, 2017
WITHDRAWN: Curcumin shifts RAS-induced pro-proliferative MEK/ERK-signaling toward pro-apoptotic p38MAPK/JNK1-signaling, triggering p53 activation and apoptosis.
Journal: The Journal of biological chemistry
Published: March 07, 2017
Intrinsic repair protects cells from pore-forming toxins by microvesicle shedding.
Journal: Cell death and differentiation
Published: August 29, 2016
Sulphur alters NFκB-p300 cross-talk in favour of p53-p300 to induce apoptosis in non-small cell lung carcinoma.
Journal: International journal of oncology
Published: March 25, 2015
Cross-talk between endoplasmic reticulum (ER) stress and the MEK/ERK pathway potentiates apoptosis in human triple negative breast carcinoma cells: role of a dihydropyrimidone, nifetepimine.
Journal: The Journal of biological chemistry
Published: December 21, 2014
Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin/β-catenin negative feedback loop.
Journal: Stem cell research & therapy
Published: April 12, 2014
Last Updated: 09/26/2026